on 23 Oct 2013
TM5 Status
DEAD/APPLICATION/ Withdrawn/Abandoned
Your application has been withdrawn or abandoned. You cannot use the TM5 mark.
Last Applicant/ Owned by
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC
2273 Research BoulevardSuite 400Rockville, Maryland 20850
US
Serial Number
1488013 filed on 8th Jul 2010
Correspondent Address
OYEN WIGGS GREEN & MUTALA LLP
480-THE STATION, 601 WEST CORDOVA STREETVANCOUVER
BRITISH COLUMBIA
CA
V6B1G1
Trademark usage description
pharmaceutical research and development of therapeutic treatments for inflammation, cancer, autoimmune diseases and diabetes. therapeutic pharmaceuti Read MoreCIPO Classification Code
Nice
CIPO Classification Code
Nice
1488013
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 7 on 23rd Oct 2013 | Abandoned - Subsection 40(3) |
Submitted for opposition 51 on 5th Apr 2013 | Allowance Notice Sent |
Submitted for opposition 50 on 5th Apr 2013 | Allowed |
Submitted for opposition 42 on 19th Dec 2012 | Advertised |
Submitted for opposition 26 on 13th Dec 2012 | Approved |
Submitted for opposition 27 on 26th Oct 2012 | Approval Notice Sent |
Submitted for opposition 12 on 11th May 2012 | Extension of Time |
Submitted for opposition 135 on 14th Mar 2011 | Amendment to Application |
Submitted for opposition 15 on 24th Jan 2011 | Correspondence Created |
Submitted for opposition 20 on 3rd Nov 2010 | Examiner's First Report |
This website uses cookies
Manage cookies
You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Advertisement
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously
Analytics
Analytical cookies are used to understand how visitors interact with the website.
Functional
Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website.